Post-Market Study to Assess iTind Safety in Comparison to UroLift

NARecruitingINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions
Benign Prostatic Hyperplasia (BPH)
Interventions
DEVICE

iTind

The iTind is implemented for 5-7 days

PROCEDURE

UroLift

UroLift is a minimally invasive procedure where permanent implants are placed in the prostate.

Trial Locations (18)

11791

RECRUITING

Feinstein Institutes for Medical Research / Northwell Health, Syosset

RECRUITING

The Smith Institute of Urology, Syosset

22311

RECRUITING

Potomac Urology Center, Alexandria

38138

RECRUITING

The Conrad Pearson Clinic, Germantown

55125

RECRUITING

Minnesota Urology, Woodbury

60201

RECRUITING

NorthShore University Health System Research Institute, Evanston

60208

RECRUITING

Northwestern University, Chicago

60611

NOT_YET_RECRUITING

Northwestern University, Chicago

68124

RECRUITING

Adult & Pediatric Urology, Omaha

70119

RECRUITING

Southeast Louisiana Veterans Health Care System, New Orleans

78240

RECRUITING

The Urology Place, San Antonio

78705

RECRUITING

Midtown Urology Associates, Austin

85704

RECRUITING

Arizona Urology Specialists, Tucson

93720

RECRUITING

Urology Associates of Central California, Fresno

95823

RECRUITING

Golden State Urology, Sacramento

KY12 0SU

RECRUITING

Queen Margaret Hospital, Dunfermline

GU16 7UJ

RECRUITING

Frimley Park Hospital, London

NR4 7UY

RECRUITING

Norfolk & Norwich University Hospital, Norwich

All Listed Sponsors
lead

Olympus Corporation of the Americas

INDUSTRY

NCT04757116 - Post-Market Study to Assess iTind Safety in Comparison to UroLift | Biotech Hunter | Biotech Hunter